| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.075 | 0.08 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.08 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.09 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |